Nanoscale Imaging Reveals Protein Abundance Does Not Guarantee Antibody Access on Cancer Vesicles
High-speed atomic force microscopy reveals that antibody accessibility of PD-L1 on cancer-derived vesicles differs from protein abundance.
High-speed atomic force microscopy reveals that antibody accessibility of PD-L1 on cancer-derived vesicles differs from protein abundance.
Seven real-world cases from a Greek neuromuscular center show how FcRn antagonists, rituximab and ravulizumab can be sequenced in generalized ...
The clinical case for expanding access to CAR T-cell therapy in Brazil rests on a substantial body of evidence demonstrating ...
Australian researchers have completed the first head-to-head comparison of three mRNA-lipid nanoparticle vaccine platforms in human blood, revealing key differences ...
A nationwide analysis of 8,104 Hungarian patients treated from 2013 to 2022 shows median survival of just 9.3 months with ...
A Brazilian study of 116 penile cancer patients found microsatellite instability in just 2.6 percent of cases but showed complete ...
A biomimetic nanoplatform cloaked in microglial cell membranes delivers carbon monoxide, manganese ions, and Gasdermin E across the blood-brain barrier ...
A new open-source Python package called ROOFS benchmarks multiple feature selection methods on a researcher's own data, evaluating predictive performance ...
A latent profile analysis of 331 lung cancer patients receiving immunotherapy identified three distinct financial toxicity groups, with lower income, ...
A comprehensive systematic review of 49 pre-treatment cohorts identifies circulating protein signatures, including inflammatory markers and T-cell activation ligands, that ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine